SSSierra Silverwood

Sierra Silverwood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sierra Silverwood has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Yelena Kier

    Munson Healthcare, Traverse City, USA

    3 shared publications
  • Adam Shulman

    Rayos Contra Cancer, Seattle, WA; Department of Radiation Oncology, University of Colorado, Colorado Springs, CO

    2 shared publications
  • Anna Jeter

    R&D Department, AOA Dx Inc, Denver, Colorado, USA

    2 shared publications
  • Bilal Jalal

    Department of Radiation Oncology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia

    2 shared publications
  • Cenji Yu

    Department of Radiation Physics, MD Anderson Cancer Center, Houston, TX

    2 shared publications
  • Claire Dempsey

    Rayos Contra Cancer, Seattle, WA; Department of Radiation Oncology, University of Newcastle, Callaghan, Australia

    2 shared publications

Latest Publications

  • A Longitudinal Assessment of Remote IMRT/VMAT Training for Medical Physicists in Low- and Middle-Income Countries

    by Sierra M. Silverwood, Caroline M. Carlson, Hong Zhu, Cesar Della Biancia, Claire Dempsey, Adam Shulman, Timothy Keiper, Sharareh Koufigar, Afua A. Yorke, Bilal Jalal, et al.


  • Evaluating interest and feasibility of climate education at a medical school in Michigan

    by Sierra Silverwood, Lena Lewis, Andrew Kim, Aaron Chang, Tyler Pham, Steven Ashmead, Harland Holman

    This study explores the incorporation of climate change into medical education by surveying about 700 students and 500 faculty at a Michigan medical school. One-way analysis of variance and post-hoc analysis assessed differences by role, age, and class year. Response rates were 9% and 8.4%. Findings show strong belief in human-induced climate change, especially among students (90%), and high concern about its effects. Both groups see climate change as a significant health issue and are willing to reduce greenhouse gas emissions. However, opinions differ on integrating climate change strategies into medical practice, with students less likely than administrators to agree (41% vs. 52%, p < 0.05). Generational differences exist regarding emission reduction actions and including climate change strategies in medical practice. The study highlights the need for climate change education in medical curricula and calls for strategic planning, student advocacy, and tailored educational content.


  • Open Access

    Benefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions

    by Karolina L Bryl, Sierra Silverwood, Krupali Desai, Kelsey Schobert, Xiaotong Li, Susan Chimonas, Jun J Mao, Erin F Gillespie

    Background: Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. Objective: This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. Methods: This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. Results: Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. Conclusions: IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. Trial Registration: ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 International Registered Report Identifier (IRRID): RR2-10.1038/s41746-024-01387-z


  • Less Is More: Hypofractionation for Equitable and Sustainable Cancer Care

    by Sierra Silverwood, Alyssa Asaro, Pratiksha Shahi, Eman Suliman, Maria S. Musa, Joseph Weygand, Kari Tanderup, Katie E. Lichter, Rohini K. Bhatia


  • Open Access

    Benefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions (Preprint)

    by Karolina L Bryl, Sierra Silverwood, Krupali Desai, Kelsey Schobert, Xiaotong Li, Susan Chimonas, Jun J Mao, Erin F Gillespie

    BACKGROUND Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. OBJECTIVE This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. METHODS This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. RESULTS Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. CONCLUSIONS IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. CLINICALTRIAL ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 INTERNATIONAL REGISTERED REPORT RR2-10.1038/s41746-024-01387-z


  • Open Access

    A unified strategy for addressing climate change, improving public health, and mitigating environmental degradation

    by Sierra M. Silverwood, Katie E. Lichter, Helena S. Kleiner, Tamiko R. Katsumoto


  • Enhancing IMRT/VMAT Competencies in LMICs globally within radiation physicists through remote training

    by Sierra M. Silverwood, Caroline M Carlson, Hong Zhu, Cesar Della Biancia, Claire Dempsey, Adam Shulman, Timothy D. Keiper, Sharareh Koufigar, Afua Yorke, Bilal Jalal, et al.


  • Exploring the impact of the COVID-19 pandemic on cancer-related distress among thoracic oncology patients at a rural cancer center

    by Sierra M. Silverwood, Douglas Peters, Veronica Bernacchi, Yelena Kier, Kelly A. Hirko

    Purpose Cancer-related distress (CRD) is frequently observed in rural settings and may have been exacerbated during the COVID-19 pandemic. We examined pre and post COVID-19 changes in CRD among individuals treated for thoracic cancers at a rural cancer center. Methods Patient demographics, clinical information, and CRD measures derived from the National Comprehensive Cancer Network psychosocial distress problem list were abstracted from electronic medical records for thoracic oncology patients treated at a rural Michigan cancer center before (January 1, 2019-January 1, 2020; n=139) and during (January 20, 2020-January 31, 2021; n=84) the COVID-19 pandemic. CRD scores were calculated by summing the items on the problem lists, and the prevalence of CRD was examined both overall and by specific sources of distress (practical, emotional, social, and physical concerns). We assessed changes in CRD overall and by type using chi-square tests, Fisher’s exact tests, and multivariable logistic regression models. Results CRD prevalence increased by 9.1% during vs. before the pandemic (97.6% vs. 88.5%; p=0.02), with the largest increases evident for emotional (82.1% vs. 64.0%; p=0.004) and physical (82.1% vs. 67.6%; p=0.02) concerns. CRD scores were slightly higher during vs. before the pandemic, but the differences were not significant (all p-values≥0.05). Compared to those treated in the year prior, patients treated during the pandemic had higher odds of elevated CRD (OR (95% CI) =1.86 (1.1, 3.2)), and practical concerns (OR (95% CI) =2.19 (1.3, 3.8)). Conclusions Findings from this preliminary study suggest an increased prevalence of CRD among rural thoracic oncology patients treated during compared to before the COVID-19 pandemic.


  • Open Access

    Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review

    by Sierra M Silverwood, Grant Backer, Annie Galloway, Katrina Reid, Anna Jeter, Margo Harrison

    Objective: Early detection of ovarian cancer can improve patient outcomes; however, screening tests can yield false-positive results, leading to unnecessary surgical interventions. This systematic review explores the prevalence of false-positive ovarian cancer screenings and subsequent unnecessary surgical interventions. Methods and analysis: Five databases were searched in March 2023 and again in March 2024, encompassing primary literature published between 2003 and 2024. Data collection focused on studies reporting the number of surgical interventions resulting from a false-positive screening result. Studies were categorized by patient risk (average vs high). Studies lacking screening or surgical intervention data, those in which the screening did not directly influence surgical decisions, or those not in English were excluded. Results: Of the 12 papers included, the majority were cohort studies (75%) based in the USA (66%). The primary screening methods included Cancer antigen 125 and transvaginal ultrasound scanning. Patients were stratified by risk, with four studies focused on high-risk populations and eight in average-risk populations. The false-positive and surgical screening rates exhibited significant variability, regardless of risk (0.1%–23.3% and 0%–54.9%, respectively). Complications associated with unnecessary surgical interventions, such as perforation, blood loss and bowel injury, were only reported in four studies. No studies examined the effect these interventions had on patients’ quality of life or directly reported the associated costs of these interventions. Conclusion: This review highlights the significant variability in ovarian cancer screening results, which lead to unnecessary and invasive surgical procedures causing complications such as perforation, blood loss and bowel injury.


  • The Promise and Challenges of AI Integration in Ovarian Cancer Screenings

    by Sierra Silverwood, Anna Jeter, Margo Harrison

    Purpose Ovarian cancer is oftendiagnosed late due to vague symptoms, leading to poor survival rate. Improved screening tests could mitigate this issue. This narrative review examines the potential and challenges of integrating artificial intelligence (A.I.) into ovarian cancer screenings, with a focus on improving early detection, diagnosis, and personalized risk assessment. Method A comprehensive review of existing literature was conducted, analyzing studies and discussions within the scientific community. Results A.I. shows promise in significantly improving the ovarian cancer screening processes, increasing accuracy, efficiency, and resource allocation. However, data quality and bias issues pose considerable challenges, potentially leading to healthcare disparities. Conclusions Integrating A.I. into ovarian cancer screenings offers potential benefits but comes with significant challenges. By promoting diverse data collection, engaging with underrepresented groups, and ensuring ethical data use, A.I. can be harnessed for more accurate and equitable ovarian cancer diagnoses.